70518-1157 NDC - PRAVASTATIN SODIUM ()

Drug Information

  • Product NDC: 70518-1157
  • Proprietary Name: PRAVASTATIN SODIUM
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: REMEDYREPACK INC.
Product Type:
FDA Application Number: ANDA207068
Marketing Category: ANDA
Start Marketing Date:5/2/2018
End Marketing Date:12/19/2022

Package Information

No. Package Code Package Description Billing Unit
170518-1157-030 TABLET in 1 BLISTER PACK (70518-1157-0)
270518-1157-190 TABLET in 1 BOTTLE, PLASTIC (70518-1157-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC70518-1157The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEPRAVASTATIN SODIUMThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE5/2/2018The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
END MARKETING DATE12/19/2022This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEANDAA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
APPLICATION NUMBERANDA207068The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
LABELER NAMEREMEDYREPACK INC.The translation of the dosage form Code submitted by the firm.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 1/16/2026

Previous Code
Next Code